HIV infection and intravenous drug use: critical issues in transmission dynamics, infection outcomes, and prevention.

As the second largest group of persons to have been infected with human immunodeficiency virus (HIV), and the most likely to transmit HIV to heterosexual partners in the United States and Europe, iv drug users will play an increasingly important role in the future of the AIDS epidemic. This paper reviews five emerging critical issues regarding HIV infection among iv drug users. In epidemiology, rates of drug injection and anonymous sharing of injection equipment appear related to rapid spread of HIV among iv drug users, while heterosexual transmission from iv drug users appears to have been occurring at a relatively slow but constant rate. Data exist that support a gender-related cofactor and a continuing drug injection cofactor, but mechanisms for these potential cofactors have not been determined. Besides frank AIDS, HIV infection also appears to lead to epidemic-level increases in a variety of fatal infections among iv drug users. Several studies of prevention show active risk reduction among iv drug users, but new methods are urgently needed to increase amount of risk reduction.

[1]  D. D. Des Jarlais,et al.  AIDS prevention among IV drug users: potential conflicts between research design and ethics. , 1987, IRB.

[2]  S. Friedman,et al.  Behavioral risk factors for HTLV-III/LAV seropositivity among intravenous drug abusers [abstract] , 1985 .

[3]  S. Friedman,et al.  Risk reduction for the acquired immunodeficiency syndrome among intravenous drug users. , 1985, Annals of internal medicine.

[4]  S. Friedman,et al.  Biological Validation of Self‐Reported AIDS Risk Reduction among New York City Intravenous Drug Users , 1988 .

[5]  D. C. Jarlais,et al.  AIDS and self-organization among intravenous drug users. , 1987, The International journal of the addictions.

[6]  P. Selwyn,et al.  Knowledge about AIDS and high-risk behavior among intravenous drug users in New York City. , 1987, AIDS.

[7]  W. Blattner,et al.  Risk for HTLV-III exposure and AIDS among parenteral drug abusers in New Jersey.: ; Atlanta, GA. , 1985 .

[8]  B. O'Donnell,et al.  HTLV-III ANTIBODY IN DRUG ABUSERS IN THE WEST OF SCOTLAND: THE EDINBURGH CONNECTION , 1986, The Lancet.

[9]  J. Phair,et al.  Predictors of the acquired immunodeficiency syndrome developing in a cohort of seropositive homosexual men. , 1987, The New England journal of medicine.

[10]  O. Schiraldi,et al.  RAPID SPREAD OF HTLV-III INFECTION AMONG DRUG ADDICTS IN ITALY , 1985, The Lancet.

[11]  D. D. des Jarlais,et al.  "Free" needles for intravenous drug users at risk for AIDS: current developments in New York City. , 1985, The New England journal of medicine.

[12]  S. Rodríguez de Córdoba,et al.  Human T-cell lymphotropic virus type III infection in a cohort of homosexual men in New York City. , 1986, JAMA.

[13]  S. Friedman,et al.  Gender differences in response to HIV infection. , 1988, Advances in biochemical psychopharmacology.

[14]  H. Ginzburg,et al.  HTLV-III exposure among drug users. , 1985, Cancer research.

[15]  S. Zolla-Pazner,et al.  Kaposi's sarcoma among four different AIDS risk groups. , 1984, The New England journal of medicine.

[16]  R. Brettle,et al.  Epidemic of AIDS related virus (HTLV-III/LAV) infection among intravenous drug abusers. , 1986, British medical journal.

[17]  T. Merigan,et al.  Cytomegalovirus infection and abnormal T-lymphocyte subset ratios in homosexual men. , 1985, Annals of internal medicine.

[18]  P. Pinsky,et al.  Disease Manifestation among Homosexual Men with Acquired Immunodeficiency Syndrome: A Possible Role of Nitrites in Kaposi's Sarcoma , 1985, Sexually transmitted diseases.

[19]  J. Goedert,et al.  Effect of T4 count and cofactors on the incidence of AIDS in homosexual men infected with human immunodeficiency virus. , 1987, JAMA.

[20]  D. D. Des Jarlais,et al.  An Overview of AIDS Prevention Efforts Aimed at Intravenous Drug Users Circa 1987 , 1989 .

[21]  D. D. Jarlais,et al.  HETEROSEXUAL PARTNERS: A LARGE RISK GROUP FOR AIDS , 1984, The Lancet.

[22]  M. Fischl,et al.  Evaluation of heterosexual partners, children, and household contacts of adults with AIDS. , 1987, JAMA.

[23]  R. Cheynier,et al.  Long-term cultures of HTLV-III--infected T cells: a model of cytopathology of T-cell depletion in AIDS. , 1986, Science.

[24]  R. Chaisson,et al.  Human immunodeficiency virus infection in heterosexual intravenous drug users in San Francisco. , 1987, American journal of public health.